Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Cancer
Interventions
DRUG

ABTL0812

ABTL0812. Five cohorts and one extension phase.

Trial Locations (1)

Unknown

Hospital Clínic, Barcelona

Sponsors
All Listed Sponsors
collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Institut Català d'Oncologia

OTHER

lead

Ability Pharmaceuticals SL

INDUSTRY

NCT02201823 - Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients | Biotech Hunter | Biotech Hunter